In the perspective of potential preclinical studies with SETD8 inhibitors, primary 5T33vv murine MM models [25] were also treated with growing concentrations of UNC-0379 for 24 hours before cell viability analysis. This evidence concerns the gene KMT5A and Miyoshi myopathy.